Stock listing
Santen Pharmaceutical Co., Ltd.
Selected listing: 4536N · BIVA · MXN · MX
Santen Pharmaceutical Co., Ltd. (BIVA:4536N), Health Technology. Latest release Sep 30, 2026: Notice on the Completion of Disposal of Treasury Shares…
- Ticker
- BIVA:4536/N
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- BIVA
- Currency
- MXN
Latest news from Santen Pharmaceutical Co., Ltd.
Notice on the Completion of Disposal of Treasury Shares for the Post-delivery Type Performance-Linked Stock Remuneration Plan
September 30, 2026
Santen Pharmaceutical : New Drug Application Filing Accepted for Review in China for STN1012700 (Atropine Sulfate Ophthalmic Solution 0.025%), an Ophthalmic Solution to Slow the Progression of Myopia
September 14, 2026
Notice on the Disposal of Treasury Shares for the Post-delivery Type Performance-Linked Stock Remuneration Plan
September 3, 2026
Summary of Consolidated Financial Results for the Three Months Ended June 30, 2026 (IFRS)
August 6, 2026
Teijin Receives Approval for Additional Indications of XEOMIN® for Cervical Dystonia and Blepharospasm in Japan
June 19, 2026
Research Santen Pharmaceutical Co., Ltd.
Santen Pharmaceutical Co., Ltd. company profile
View the public company page for Santen Pharmaceutical Co., Ltd. on 6ix.
Santen Pharmaceutical Co., Ltd. news
Read company news and market updates connected to Santen Pharmaceutical Co., Ltd..
Santen Pharmaceutical Co., Ltd. investor events
Find investor webinars, events, and replay context for Santen Pharmaceutical Co., Ltd..
Alternate listings
4536:TSE
JP · JPY
Alternate listing for Santen Pharmaceutical Co., Ltd.; the primary context on this page is 4536N:BIVA.
SNPHY:OTC
US · USD
Alternate listing for Santen Pharmaceutical Co., Ltd.; the primary context on this page is 4536N:BIVA.
864318:LSX
DE · EUR
Alternate listing for Santen Pharmaceutical Co., Ltd.; the primary context on this page is 4536N:BIVA.
864318:LS
DE · EUR
Alternate listing for Santen Pharmaceutical Co., Ltd.; the primary context on this page is 4536N:BIVA.
SNPHF:OTC
US · USD
Alternate listing for Santen Pharmaceutical Co., Ltd.; the primary context on this page is 4536N:BIVA.
SZD:GETTEX
DE · EUR
Alternate listing for Santen Pharmaceutical Co., Ltd.; the primary context on this page is 4536N:BIVA.
SZD:FWB
DE · EUR
Alternate listing for Santen Pharmaceutical Co., Ltd.; the primary context on this page is 4536N:BIVA.
SZD:TRADEGATE
DE · EUR
Alternate listing for Santen Pharmaceutical Co., Ltd.; the primary context on this page is 4536N:BIVA.
SZD:DUS
DE · EUR
Alternate listing for Santen Pharmaceutical Co., Ltd.; the primary context on this page is 4536N:BIVA.
SZD0:GETTEX
DE · EUR
Alternate listing for Santen Pharmaceutical Co., Ltd.; the primary context on this page is 4536N:BIVA.
SZD:HAN
DE · EUR
Alternate listing for Santen Pharmaceutical Co., Ltd.; the primary context on this page is 4536N:BIVA.
4536N:BMV
MX · MXN
Alternate listing for Santen Pharmaceutical Co., Ltd.; the primary context on this page is 4536N:BIVA.